Key result
Overall mortality was 13%, and 15-year survival or freedom from re-operation did not differ significantly between patients receiving valve replacements and those receiving valve repair (p=0.76).
Why the study?
Outcomes of the minority proportion of rheumatic heart disease patients who access surgery have not been described in Uganda.
Cohort (n=359)
Yes
p-value: p=0.76
Surgical valve procedures for rheumatic heart disease in Uganda are associated with a 13% overall mortality and similar long-term outcomes between repair and replacement, highlighting the critical need for expanded post-operative care and sustainable healthcare financing.
Surgical outcomes data from Uganda inform local care; leaves open generalizability and long-term impact in LMICs.
Background: Chronic valvular heart disease is a well-known, long-term complication of acute rheumatic fever (ARF), which remains a major public health problem in low- and middle-income countries. Access to surgical management remains limited. Outcomes of the minority proportion of patients that access surgery have not been described in Uganda. Objectives: To describe the volume and type of rheumatic heart disease (RHD) valvular interventions and the outcomes of operated patients in the Uganda RHD registry. Methods: We performed a retrospective cohort study of all valve surgery procedures identified in the Uganda RHD registry through December 2021. Results: Three hundred and sixty-seven surgical procedures were performed among 359 patients. More than half were among young (55.9% were ≤20 years of age), female (59.9%) patients. All patients were censored at 15 years. The median (IQR) follow up period was 43 (22,79) months. Nearly half of surgeries (46.9%) included interventions on multiple valves, and most valvular operations were replacements with mechanical prostheses (96.6%). Over 70% of the procedures were sponsored by charity organizations. The overall mortality of patients who underwent surgery was 13% (47/359), with over half of the mortalities occurring within the first year following surgery (27/47; 57.4%). Fifteen-year survival or freedom from re-operation was not significantly different between those receiving valve replacements and those receiving valve repair (log-rank p = 0.76). Conclusions: There has been increasing access to valve surgery among Ugandan patients with RHD. Post-operative survival is similar to regionally reported rates. The growing cohort of patients living with prosthetic valves necessitates national expansion and decentralization of post-operative care services. Major reliance on charity funding of surgery is unsustainable, thus calling for locally generated and controlled support mechanisms such as a national health insurance scheme. The central illustration (Figure 1) provides a summary of our findings and recommendations.
No takes yet. Share an insight, caveat, or question.
Rwebembera et al. (2023) conducted a cohort in Rheumatic Heart Disease (n=359). Valve replacement vs. Valve repair was evaluated on 15-year survival or freedom from re-operation (p=0.76). Overall mortality was 13%, and 15-year survival or freedom from re-operation did not differ significantly between patients receiving valve replacements and those receiving valve repair (p=0.76).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: